Crossmark

Effective management of necrotizing crescentic glomerulonephritis using an aggressive combination therapy including avacopan in a patient double-seropositive for anti-GBM antibodies and ANCA: a case report

Crossref DOI link: https://doi.org/10.1007/s13730-024-00929-4

Published Online: 2024-09-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tanaka, Rina

Toishi, Takumi

Masaki, Reiji

Aihara, Hideaki

Sakamoto, Sumie

Ikeda, Mari

Inoue, Tomohiko

Kawaji, Atsuro

Matsunami, Masatoshi

Fukuda, Junko

Ohara, Mamiko

Kuji, Hiroshi

Ichikawa, Daisuke

Suzuki, Tomo https://orcid.org/0000-0001-5536-1741
License Information

Text and Data Mining valid from 2024-09-10

Version of Record valid from 2024-09-10
More Information

Article History

Received: 21 February 2024

Accepted: 3 September 2024

First Online: 10 September 2024

Declarations

:

: All authors declare no competing interests.

: This case study was conducted in accordance with the Declaration of Helsinki.

: Informed consent was obtained from the participants included in the study.

Document is current

Any future updates will be listed below